Physician profile
Vicky Snyder
NPI 1386814622
$7,638.15
in general payments reported to CMS, 2019-2025
39 companies · $2,771 in 2025
The $2,771 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $686 · 2022: $905 · 2023: $1,329 · 2024: $1,946 · 2025: $2,771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,978 · Education: $68.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,977.69 |
| Education | $68.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,093.79 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $818.29 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $702.89 | 2021-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $578.04 | 2021-2025 | Evenity, Repatha, Repatha |
| Xeris Pharmaceuticals, INC. | $439.95 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Insulet Corporation | $392.40 | 2022-2025 | Omnipod, Omnipod |
| Cequr Corporation | $390.68 | 2024-2025 | Cequr Simplicity |
| Radius Health, INC. | $359.00 | 2023-2025 | Tymlos |
| Corcept Therapeutics | $335.08 | 2023-2025 | Korlym |
| Sequel Med Tech, LLC | $280.32 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $259.91 | 2021-2024 | |
| Medtronic, INC. | $250.01 | 2022-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Beta Bionics, INC. | $211.21 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Tandem Diabetes Care, INC. | $195.41 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.62 | 2022-2025 | Jardiance |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicky Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.